05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
On December 20, 2019, President Trump signed into law the Further Consolidated Appropriations Act, 2...
Read More >
Right of First Refusal EO Revoked. Last week, President Trump issued an Executive Order revoking Exe...
Read More >
Prior to July 2nd, New Jersey’s Medical Cannabis Act lacked protections for employees’ off-duty me...
Read More >
Liability insurers charge premiums in exchange for an agreement to cover certain claims against thei...
Read More >
The Oregon legislature was active in 2019. Several new laws were passed that impact employers, inclu...
Read More >
In this, the second bulletin in our series, we take a look at Pillar Two of the "Planning for the Fu...
Read More >